Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models

(2011) Mark Jit et al.   BMC Medicine

During The ‘Decade Of Vaccines,’ The Lives Of 6.4 Million Children Valued At $231 Billion Could Be Saved

(2011) Sachiko Ozawa et al.   HEALTH AFFAIRS

Estimated Economic Benefits During The ‘Decade Of Vaccines’ Include Treatment Savings, Gains In Labor Productivity

(2011) Meghan L. Stack et al.   HEALTH AFFAIRS

Modelling the Epidemiology of Infectious Diseases for Decision Analysis

(2011) Mark Jit et al.   PHARMACOECONOMICS

Economic evaluation of pneumococcal conjugate vaccination in The Gambia

(2010) Sun-Young Kim et al.   BMC INFECTIOUS DISEASES

Willingness to pay for three hypothetical malaria vaccines in Nigeria

(2010) Waka Anthony Udezi et al.   CLINICAL THERAPEUTICS

Economic analysis of the global polio eradication initiative

(2010) Radboud J. Duintjer Tebbens et al.   VACCINE

Cost-effectiveness of the CRM-based 7-valent pneumococcal conjugated vaccine (PCV7) in Argentina

(2010) Norberto D. Giglio et al.   VACCINE

Rethinking the benefits and costs of childhood vaccination: The example of the Haemophilus influenzae type b vaccine☆

(2010) Till Bärnighausen et al.   VACCINE

Comparative impact assessment of child pneumonia interventions

(2009) Louis Niessen   BULLETIN OF THE WORLD HEALTH ORGANIZATION

30 Years of Pharmaceutical Cost-Utility Analyses

(2009) Peter J. Neumann et al.   PHARMACOECONOMICS

Cost Effectiveness in Low- and Middle-Income Countries

(2009) Samuel D. Shillcutt et al.   PHARMACOECONOMICS

The impact of immunization on the association between poverty and child survival: Evidence from Kassena-Nankana District of northern Ghana

(2009) Ayaga A. Bawah et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Cost–benefit comparisons of investments in improved water supply and cholera vaccination programs

(2009) Marc Jeuland et al.   VACCINE

Cost-Effectiveness of New-Generation Oral Cholera Vaccines: A Multisite Analysis

(2009) Marc Jeuland et al.   VALUE IN HEALTH

Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern

(2008) P. Beutels et al.   HEALTH ECONOMICS

The demand for a dengue vaccine: A contingent valuation survey in Metro Manila

(2008) Rosalina Palanca-Tan   VACCINE

Household Demand for Preventive HIV/AIDS Vaccines in Thailand: Do Husbands' and Wives' Preferences Differ?

(2008) Dale Whittington et al.   VALUE IN HEALTH

Private Demand for Cholera Vaccines in Hue, Vietnam

(2007) Dohyeong Kim et al.   VALUE IN HEALTH